Charles Stockham, Ph.D., has been recruited as executive vice president of PACS integrator DeJarnette Research Systems. Stockham, a Cornell University-educated physicist, has more than 23 years' experience in medical imaging and holds several patents. He
Charles Stockham, Ph.D., has been recruited as executive vice president of PACS integrator DeJarnette Research Systems. Stockham, a Cornell University-educated physicist, has more than 23 years' experience in medical imaging and holds several patents. He will provide guidance on future product development and technology assessment and serve as DeJarnette's representative to the DICOM and HL7 committees.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.